Opinions, reviews, analyses & recommendations are the author’s alone, and have not been reviewed, endorsed or approved by any of these entities. UponArriving has partnered with CardRatings for our coverage of credit card products. UponArriving and CardRatings may receive a commission from card issuers.
We just received more good news regarding a potential coronavirus vaccine.
The Moderna vaccine is 94.5% affective against the coronavirus according to early research data that was released by the company today.
The high success rate has a lot of experts feeling very optimistic about the vaccine.
“These are obviously very exciting results,” said Dr. Anthony Fauci.
“It’s just as good as it gets — 94.5% is truly outstanding.”
The results came from the Data Safety and Monitoring Board, which is an independent panel analyzing Moderna’s clinical trial data.
Members of Moderna were thrilled to hear the results.
“It was one of the greatest moments in my life and my career. It is absolutely amazing to be able to develop this vaccine and see the ability to prevent symptomatic disease with such high efficacy,” said Dr. Tal Zacks, Moderna’s chief medical officer.
It’s expected that vaccinations could begin to be administered in the second half of next month and that they will begin with high-risk groups.
Closer to the spring, the vaccines will be available to the rest of the population.
The actual participant results were pretty interesting.
15,000 study participants were given a placebo and over the course of several months, 90 of them develop the coronavirus. Of those 90, 11 developed severe forms of the disease.
Out of the 15,000 participants who were given the vaccine, only five of them developed coronavirus and none of them became seriously ill.
So it seems that even when you contract the virus after getting vaccinated, your odds of getting seriously ill decrease (probably pretty dramatically).
It was also reported that the vaccine did not have any serious side effects.
The only side effects that were reported were mild symptoms such as body aches and headaches but those were only a small percentage of the participants.
At a time when we are likely looking at more lockdowns coming our way in the next couple of weeks, this news is very up-lifting.
It suggests that in a matter of only another month or two, members of the public will begin getting vaccinated and we will start to be on the path back to normalcy.
If everything goes according to plan, next summer could be the time everybody has been waiting for where group gatherings no longer pose a serious risk and large stadium venues can open back up.
We just need to get through the middle of winter and we should be off to the races!
UponArriving has partnered with CardRatings for our coverage of credit card products. UponArriving and CardRatings may receive a commission from card issuers. Responses are not provided or commissioned by the bank advertiser. Responses have not been reviewed, approved or otherwise endorsed by the bank advertiser. It is not the bank advertiser’s responsibility to ensure all posts and/or questions are answered.
Daniel Gillaspia is the Founder of UponArriving.com and creator of the credit card app, WalletFlo. He is a former attorney turned full-time credit card rewards/travel expert and has earned and redeemed millions of miles to travel the globe. Since 2014, his content has been featured in major publications such as National Geographic, Smithsonian Magazine, Forbes, CNBC, US News, and Business Insider. Find his full bio here.